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Human leukocyte antigen (HLA) associations have 
been reported in Amerindian patients with actinic 
prurigo. To determine if silnilar associations are 
present in the British Caucasoid population with 
actinic prurigo, 26 patients underwent serological 
typing for HLA Class I and II antigens. DNA analysis 
by both sequence-specific priming and group-specific 
amplification with single-stranded oligonucleotide 
probe hybridization was used to confirm the DR and 
DQ typing and to perform DR4 subtyping. All pa-
tients were DR4 positive, and 25 of 26 patients were 
A ctin ic prurigo (AP) is a rare, chroni c, cutaneous photosensitivity disorder of generally childhood on-set and fel11a le predominance . It is characterized by the presence of persi stent excoriated papules, nod-ules, and plaques, occasiona lly with eczem atous 
change and cheilitis, on m ainly li ght-ex posed sites, occasionall y 
with shall ow, linear , pitted scars [1]. T he condi tion is also fo und 
m ore freq uently in nati ve American (Amerindian) po pulations, 
where it is often fa milial [2] and of late o nset [3]. 
AP is generall y held in Britain to be di stinct from polymorphic 
ligh t erupti on (PLE), although part of the sa me spectrum of disease , 
as som e patients ha ve overlapping features of both conditions [1]. 
T hi s rema ins controversial, however, and othe rs be lieve AP to be a 
subgroup of PLE [4). PLE is a common photodermatosis, of onset 
generally in the first three decades of l.ife, characterized by the 
interm.ittent appearance of erythematou s papules, vesicl es, and 
plaques. Invo lvement of covered areas is unusual. There is gener-
ally a clear re lation to prior ultravio let ex posure, with onset of 
lesions w ithjn ho urs, occasiona lly days, fo llowing exposure; the 
eruption then generally subsides without sca rring within days to 
weeks. 
T issue typi ng of Colo mbian A.m erindians with AI' has demon-
strated an apparentl y increased frequency of human le ukocyte 
antigen (HLA) Cw4 [2]; other ini tiall y reported associations with 
B40 and Cw3 have later been discounted [2]. Canadian A.merindi-
'1I1S also have an increased frequency also of H LA Cw4, w hich 
although not statisti ca lly significant is like ly to be relevant in 
conjunction with the Colo mbi an data, and 3n increased frequency 
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DQ7 positive . DR4 subtyping revealed 12 of 20 pa-
tients tested to be DRBl*0407. A nonsignificant as-
sociation was also found with HLA B55 that is in 
linkage disequilibrium with DRBl*0407. No HLA 
associations were found in 25 British Caucasoid pa-
tients with polymorphic light eruption. DRBl*0407 is 
rare in European Caucasoids without actinic prurigo, 
and HLA-DR4 may have an important role in deter-
mining expression of this disease. K eJ' 1V00'ds: plrotosell-
sitivitJ'/p/lOtodel'llla,toses/tisslle typillg. ] Illvest D a lila to/ 
106:362-364, 1996 
ofHLA A24 [5] . Such associations ma y well have an important role 
in determining dise'lse expressio n and we ha ve therefore studied 
the HLA status of British Ca ucasoid patients with AP to establish if 
similar associa tions are present. Ethnic variatio ns in HLA disease 
associations arc well recogni zed , however, and therefore all pa-
tients and contro ls in this srudy were ca refull y chosen to be Britjsh 
Ca ucaso ids. 
MATERI ALS AN I METHODS 
All Caucaso id patients w ith a clinica l d iagnos is of acti ni c prurigo seen in the 
Department of Photobiology o f the St. J o hn 's Insti tute of Derma tology 
at St. T homas' H ospital over a 'I-y period were studi ed along with 25 
Ca ucaso id parients w ith PLE. AP was distinguished fro m pLE by rhe 
presence o f all or severa l of the fo llowing features: the presence of persis rent 
lesions w ith p rurigo papu les or nodules . a tende ncy to activity in wimer. the 
presence o fl csio ns o n covered sites, CczcJ1wtizario ll of lcs io lls. a tend ency to 
superfi cial sca rring. and assoc iated cheili t.is or conjunctiv itis, although none 
of these features was diagnostic in iso latio n , Patie nts with overla p fea tures of 
actinic prurigo aud polym orphic li ght eruption, as . for example. w ith lesions 
on exposed sites of greater than 2-wk du ration but no other associated 
features of AI', were excluded in order to ensure that the patient groupS 
were distinct. V cnesection was perfo rmed following ve rbal consent from 
the patient. 
Serological Typing Serological typi.ng fo r I-ILA C lass I and II antigens 
was performed ill all patients by means of a sta ndard Iymphotoxicity assay, 
with we ll-characterized antisera for HLA-A , -B, -C. -Dlt. and -DQ. The 
results we re compared with those of 292 normal. previously tissue-typed 
Caucaso id control patients. 
Confirmation of Serology T he I-I LA C lass II sero logical res ul ts were 
confirmed b), the mo re d iscrimina tory method of genot)'ping in 20 AI' 
patients. T he typi ng fo r D I~13 was by po lyme rase chai n reactio n (PC R)/ 
sequence-spec ifi c priming afte r the method of Olerup ", ti l 161, the priJllers 
and pro bes o btained 'IS kits fro m the 13ritish Society of Histocompa tibil ity 
and IItlTllln lOgcnetics . and that for DQ by PClt/sequence- specifi c priming 
after the me thod o fJ3uncc and co ll eagues r71. from w hom the primers were 
obtained; DNA was extracted in each instance by the sa lt method [8]. These 
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Tabl e I. HLA-DR4 (predominantly DRBt"'0407) Is Present in Patients with Actinic Prurigo" 
Patient HlA-A HlA-B HlA-C HlA-O R HlA-OQ OR-4 Subtype 
1 2,3 44 .60 7 4. "11 7.8 0403 
2 II ,X 35, 4 4,11 7,7 0407 
3 2.X 35.55 3.4 4,1.1 7.7 0408 
4 3,28 27 ,44 2,7 43,4 6.7 0407 
5 32,X 7,55 3,7 ~. 2 6,7 0407 
6 1,11 8.51 4,7 4.3 2.7 0407 
7 1,3 1 8.60 3,7 4.13 6.7 0404 
8 28,3 1 52 .62 3 4,6 5.7 0407 
9 3.25 7. 18 7,X ~ , 7 2.8 0401 
10 I,ll 55 ,57 3.6 4,7 7,9 0407 
11 1,3 44 ,60 3.X 4,7 2,7 0407 
12 3.X 35 .27 2.4 4,9 7.9 0407 
13 11,29 51 .7 4,X 4,4 7,7 0407.0407 
14 2.25 44.X S.X 4.4 7,8 0401 .0401 
15 2, 11 3<),55 3.7 4,4 7.8 040 ] .0407 
16 2,3 8,44 5,7 4,4 7,7 0401 
17 1,29 8.44 7,X 4.4 7,7 0401,0401 
18 1,2 44,55 3, 4,1 1 7.7 0407 
19 28,29 44.X 7.X 4.4 7,7 0407 .0407 
20 2.25 7.60 7,X 4,4 7,X 0404 .0407 
or 
0403.0408 
21 2,X 7.35 4,7 ~,1 5,7 NP 
22 3,25 7, 18 7.X 4.2 1,7 NP 
23 1,2 55,60 3.X 4,6 1,7 NP 
24 2,2<) 44,X 5,X 4,X? 7,X Nl) 
25 2.3 7.44 5.X 4,X? 7.X NP 
26 2,3 27,44 2,5 4.X? 7,X NI) 
n X . possib ili ty or:lIl 1IIldc[Ct:lcd antigell 0 11 serol ogical typing nl Ol Il.! as r.11l1 i1ies were nor tcs[Cd ill this study; NP. not perrormed. 
results were then compared with those of a separate group of 177 normal 
Caucaso id controls typed at the ORl3 and OQA and \3 subregions by 
group-spec ific ampli fi ca tion using PC R fo llowed by single-stranded oligo-
nucleotide probe hybridiz:ltion [9]. 
DR4 Subtyping Although DR4 is s"rologica lly homogeneous. it may be 
further defined by rnolecul :lr techniques into at least 14 differ"llt subtypes. 
Subtyping was p"rfonlled by PCR/single-s tranded o ligonucleoLide probe 
hybridization using the rn"thod of lanchbury e/ nl I I 0], with the modifica-
tion that prob"s were l:lbekd with Auor"scein, and detection of hybridiza-
tion was by tb." ECl sYStl! 1l1 ( I~P 3000; Amershalll In ternational. Little 
Cha lfont, Bucks. U.K.). Essentiall y. the oligonucleotide probes [1 0] were 3' 
eud labelled by d"oxynucleotide transferase with Hlioresc"in-dUTP. Hy-
bridiza tion took place using the reag"nts provided with stringent washes 
(10] and detected with an anti-Auoresce in horse radish peroxidase conjugate 
(supp lied) . BOll nd p"roxidase was detected through tl le enzymatic reduc-
tion of peroxidase to luminol (supplied) in the presence of a.l l enhancer 
(supp lied) and the resu ltan t light emission detected usin!, closely opposed 
XAR5 film (Kodak). The r"slllts were confirl11"d by PCR./sequence-
specific priming J"lIJ . 20 consecutive unrelated O RA subjects of unknown 
subtype and 5 OR4 homozygous ce ll lines being simul taneous ly ana lyzed as 
controls; these cell lines were chosell to include Ow4 (01U31 ' 040"111: 
Priess), Ow'l 0 (0 IU3 'I*0402l2: PV9). Ow 14 (OR.WI ' 0404/4: MTF), Dwl S 
(DRB1*040S/5: SJAH). and Ow 13. spec ifically sdect"d as 0 1U31 ' 0407 
(ORl31*040717; JHAF). 
Statistical A nalysis Fishe r' s exact tcst was used to calculate the signi f-
icance of allY H LA associations noted in AI', a correction factor of 100 being 
used fo r tile nllmber of antigens tested (l-LLA-A 22. - 13 40, -C 8, -DR "15. 
-DR4 8 , -OQ 7) . and the corrected probability being quoccd :IS p, ' T he 2 X 
2 table was used to calcu late chi-square fo r independence with Yates 
correction. 
RESULTS 
Twenty-six AP patients were studied. 21 fema le and 5 male with 
ages rang in g from 7 to 50 y, the average age of d isease o nset being 
14 y . Twenty-tive PLE patients were also studi ed, 2 '1 fem a le and 4 
mal e w ith ages rang in g fro l1l 7 to 43 y the average age of disease 
onset bei ng 23 years . T he age of the health y controls ranged fi'om 
5 to 60 yea rs. 
Class I Typing No significant C lass I assocIation was found, 
although 6 of26 patients were HLA-B55 compared w i th 11 of292 
controls (,I = 14, Fp = 0.0011. Fpc = 0.11); th ere were also very 
slig h t increases in HLA-Cw4 and - Cw3 n ot approaching statistical 
sign.ificance. No patient was HLA-A24. No distortion of antigen 
frequen cy was present in the PLE g ro up . 
Class II Typing All 26 AP patients were HLA-DR4 (Table I) in 
contrast to onl y 70 of 177 controls (X2 = 31, Fp = 4.46 E-l 0 
[0.00000000045] , Fpc = 4.46 E- 7 [0 .00000045]). Ten pa tients were 
ho m ozygous for DR4. Twen ty-fi ve of 26 patients were DQ7 
compat'e d w ith 53 of177 contro ls (X2 = 39, Fp = 4.7 E-1 1, Fp,' = 
4.7 E- 9 [0.0000000047]) . Only 9 of 25 PLE patients w e re HLA-
OR4 (X2 = NS). 
DR4 Subtyping Twelve of 20 AP patie n ts tested were subtype 
O R Bl *0407 (Table I) but none of20 con tro ls (X2 = 14.4, Fpc = 
0.000023, Pc = 0.002), w ho showed instead the subtype freq uen cy 
distribution expected of Briti sh Caucasoid s l1 1,12] . One of the 
h o m ozygous patients (P'ltient 20) was OR4 Ow13 (DRB1 *0403 or 
0407) and OR4 Ow14 (ORB1 *0404 or 0408) but n o furth er 
sub type ass ig nment was possible w ith the availabl e technology: this 
patient has not been included as OR.B ! *0407. 
D ISCUSS ION 
We have shown compl ete concordance between AP and the C lass 
II antigen HLA -DR.4 in the 26 patie nts studied , clearly a hig hl y 
significant association. Further analysis has also revealed a stron g 
assoc iation w ith the DR4 subtype ORB1 *0407. In addition , we 
have shown a strong association w ith the C lass II antigen HLA-
OQ7 alld a weaker, not statistically signi ficant, association w ith the 
C lass [ antigen HLA-B55. No significan t distortio n in antigen 
frequency was detected at the HLA-A24. -Cw4. and - Cw3 loci, 
however, and , the refore. o ur data do not repeat the previous 
findings of C lass I assoc iatio ns in Amerindians with AP [2.5]. The 
weak associatio n found b y us w ith .1355 is likel), to be related to its 
lin kage with ORB 1 *0407 l1 2] . T he strong association with OQ7, 
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found in 25 of o ur 26 patients may well be for the same reason, as 
DQ7 is also in lin kage with DRB1 *0407 in the British population 
[12,13]. It remains possible that DQ7 is of primary importance, but 
thi s is relati ve ly unlikely as no increase was o bserved in HLA-DR5, 
w hich is associated with DQ7 in British Caucasoids. DRBl *0407 is 
un common in Europea n Ca ucasoids, making up 4.4 - 6.7% of 
DR4-positive individuals depending on the group studied [12,13]. 
Thus, its m arkedly increased incidence in o ur patients with AP 
seem s likely to be o f pathogenic signifi can ce. 
HLA-DR4 has previo usl y been found to be associated with a 
number of autoimmune diseases, notably rheumatoid arthritis [13] 
and a number of skin diseases particularly pemphigus vu lgad s in 
J ewish patien ts, vitiligo, drug-induced lupus erythematosus, and 
herpes gestation is (DR4/DR3 heterozygotes) [1 4, 15]. The precise 
significance of such HLA associations in the pathogenesis of disease 
has no t been elucid ated, but it has been postulated that different 
individual s vary in their response to different antigens and that this 
variation is determined genetically and !.inked to the major histo-
compatibiJity complex. HLA restriction may thus determine bind-
in g of particular disease-related peptides, or alternatively alert 
specific T -cell reperto ires. Since AP has features suggesting it may 
be a T cell-mediated immunological disorder [1] , and since the 
DR4 gro up of alleles, varying considerably in the third hyperv ari-
able regio n which is believed to inte ract with th e T-cell receptor, 
have distinct T -cell specifi cities, class II restriction in AP may 
conceivably determin e the T-cell response. On the other hand, and 
perh aps more likely, since direct comparison between the 3-dimen-
sional crystal structure ofHLA-DR1 (DRB l *0101) [1 6] and that of 
DRB1 *0407 indicates that the positions that make DRBI *0407 
uniqu e from o ther DR..4 all eles (positions 74 and 86) are intimately 
in vo lved in peptide binding, the HLA type in AP may instead 
determine the response to a peptide antigen, conceivably one 
induced by ultravi olet irradiati o n, to initiate the characteristic AP 
cutaneous response. 
DRB1 *0407 is more common in Amerindians than in Cauca-
soids, which may possibly help explain the greater prevalence of AP 
in that population; since DRBl *0407 is associated with DQ8 and 
not DQ7 in Amerindians [17]. C lass IT typing is now aw aited with 
interest in tbat ethnic group and may reveal such a link. Serological 
DR4 typin g has already been pe rformed in Colombian Amerindi-
ans, showing an initial increase in DR4, which was not, ho wever, 
stati stically significant nor later confirm ed [2). N ewer methods may 
now conceivably reveal such an association. Of considerable in ter-
est, 110 HLA associations w ere found in PLE patients, confirming 
pre vi o ll s findings in Canadian Ca ucasoids and suggesting that PLE 
is distin ct ii-om AP [1 8] . T he HLA C lass II antigen DR4 thus 
appea rs to be strongly associated with AP in British Caucasoid 
patients and may therefore ha ve a causal ro le in the pathogenesis of 
the disease by determining or modifyi ng the response in the disease 
to a li gh t-induced antigen . In contrast, the absence of an HLA 
association in l)LE suggests that, at least in British Caucasoids, tllis 
disting uishes the clinical responses in the two patien t groups and 
may thus act as a marker to distinguish the two conditions. Study of 
patients with overlap features of AP/PLE will now be ofil1terest to 
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delineate more cl early the role of HLA genes in expression of the 
two diseases . Further study of Amerindian patients is also needed to 
determin e whether the HLA association in AP explains the greater 
prevalence of th e disease in those populations. 
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